UnknownPHASE1, PHASE2NCT03079401
Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle
Studying Atrioventricular septal defect
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Boston Children's Hospital
- Principal Investigator
- Sitaram M Emani, MDBoston Children's Hospital
- Intervention
- MPC; rexlemestrocel-L(biological)
- Enrollment
- 19 enrolled
- Eligibility
- 5 years · All sexes
- Timeline
- 2017 – 2024
Study locations (1)
- Boston Children's Hospital, Boston, Massachusetts, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03079401 on ClinicalTrials.govOther trials for Atrioventricular septal defect
Additional recruiting or active studies for the same condition.